insights_auto
Why is CAMX up ၈.၂၀%?
Dive Deeperchevron_right
CAMX:STO
Camurus AB
၇၁၉.၅၀ SEK
arrow_upward
+၈.၂၀%(+၅၄.၅၀) 1D
နို ၅, GMT+၁ ၁၁:၁၄:၀၆ · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CAMX...
Open
၇၀၄.၅၀ SEK
High
၇၃၇.၀၀ SEK
Low
၇၀၀.၅၀ SEK
Mkt. cap
ဋေ ၄.၁၀ ထ
Avg. vol.
၉.၀၄ သောင်း
Volume
၁.၄၂ သိန်း
52-wk high
၇၃၇.၀၀ SEK
52-wk low
၄၃၀.၈၀ SEK
Shares outstanding
၆.၀၆ ကုဋေ
No. of employees
၃၁၆
Open
၇၀၄.၅၀ SEK
High
၇၃၇.၀၀ SEK
Low
၇၀၀.၅၀ SEK
Mkt. cap
ဋေ ၄.၁၀ ထ
Avg. vol.
၉.၀၄ သောင်း
Volume
၁.၄၂ သိန်း
52-wk high
၇၃၇.၀၀ SEK
52-wk low
၄၃၀.၈၀ SEK
Shares outstanding
၆.၀၆ ကုဋေ
No. of employees
၃၁၆
News stories
From web sources and news partners
Investing.com
·
ပြီးခဲ့သည့် ၂ နာရီ
Camurus third quarter revenue beats expectations on Buvidal gains
TradingView
·
ပြီးခဲ့သည့် ၄ နာရီ
CAMX: Record sales and earnings, strong cash, and advancing CAM2029 and Oczyesa milestones
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
About Camurus AB